Sponsor or institution
Clinical trials and research at Lantern Pharma Inc.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Lantern Pharma Inc. that are recruiting, at sites in 3 countries (most in United States (2), Japan (1), Taiwan (1)). By phase: Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 3Countries
All recruiting trials (2)
-
Evaluating LP-284 for patients with relapsed or refractory lymphomas and solid tumors
This study is testing a new drug called LP-284 to see if it is safe and effective for adults with relapsed or hard-to-treat lymphomas and advanced solid tumors.
-
LP-300 with Carboplatin and Pemetrexed for Never Smokers with Advanced Lung Adenocarcinoma
This study is testing if adding a new drug called LP-300 to standard chemotherapy can help people who have never smoked and have advanced lung adenocarcinoma live longer and feel better.
Quick answers
How many clinical trials run by Lantern Pharma Inc. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (2 trials), Japan (1 trial), Taiwan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.